EventsKGLBCatalyst eventTakeda Pharmaceutical Co Ltd (TAK)From KEDI Global Longevity Bio Index (KGLB)China's NMPA approved Takeda's ORZEYFUL (oveporexton) for narcolepsy type 1 in patients aged 16 years and older.Korean translation중국 NMPA가 16세 이상 기면증 1형 환자 대상 다케다의 ORZEYFUL(oveporexton)을 승인함.
